Enliven Therapeutics (ELVN) AI Analysis

ELVN$47.70-0.60 -1.25%
BiotechnologyGrowth Stock
Compare
Market cap$3.51BEnterprise value$3.62BRevenue (TTM)$0Market position—

Score

68
Bullish
Value
58
Quality
47
Growth
100

Enliven Therapeutics is a growth-led story right now — Growth 100/100 is the pillar doing the heavy lifting (overall 68/100) in Biotechnology. In Biotechnology, that score mix is usable but not one-dimensional. Street targets still imply ~60% upside.

Enliven Therapeutics (ELVN) AI Analysis

ELVN price $47.70 -0.60 -1.25%

Ticker
ELVN
Price
$47.70
Change
-0.60 -1.25%
Market cap
$3.51B
Dividend yield
0.00%
Beta
0.24
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
68
Value
58
Quality
47
Growth
100

Stocklytics score rationale: value 58, quality 47, growth 100.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener